Revenue and Profitability - The company's revenue for Q1 2023 was ¥2,173,950,218.46, representing a 32.59% increase compared to ¥1,639,594,622.68 in the same period last year[8] - The net loss attributable to shareholders was ¥663,780,161.59, a slight improvement of 1.47% from a loss of ¥673,650,083.21 in the previous year[8] - The basic earnings per share were -¥0.36, showing a 2.70% improvement from -¥0.37 in the same period last year[8] - The net loss for Q1 2023 was CNY 664,388,151.85, slightly improved from a net loss of CNY 671,194,899.77 in Q1 2022[22] - The company reported a basic and diluted earnings per share of -0.36, compared to -0.37 in the same period last year[22] Cash Flow - The net cash flow from operating activities increased by 368.52%, reaching ¥245,854,537.22, compared to a negative cash flow of ¥91,557,968.08 in the same period last year[8] - The net cash flow from operating activities for Q1 2023 was ¥245,854,537.22, a significant improvement from -¥91,557,968.08 in Q1 2022, indicating a positive turnaround in operational efficiency[25] - Total cash inflow from operating activities reached ¥3,116,676,278.53, compared to ¥2,075,908,249.83 in the previous period, reflecting a year-over-year increase of approximately 50.2%[25] - The cash outflow from operating activities was ¥2,870,821,741.31, up from ¥2,167,466,217.91, resulting in a cash outflow increase of about 32.5%[25] - The net cash flow from investing activities was ¥351,528,662.69, a recovery from -¥339,392,692.82 in the same quarter last year, showcasing improved investment returns[25] - Cash inflow from investing activities totaled ¥556,359,391.80, a substantial increase from ¥16,900,163.65 in the previous year[25] - The total cash outflow from investing activities decreased to ¥204,830,729.11 from ¥356,292,856.47, indicating a reduction in capital expenditures[25] - The net cash flow from financing activities was -¥319,741,930.83, slightly improved from -¥320,981,489.91 in Q1 2022, showing stabilization in financing operations[26] - The total cash inflow from financing activities was ¥1,639,900,000.00, compared to ¥1,496,940,500.00 in the previous period, marking an increase of approximately 9.5%[26] - The ending cash and cash equivalents balance was ¥738,486,076.05, down from ¥897,236,421.70 in the previous year, reflecting a decrease of about 17.7%[26] - The company reported a cash increase of ¥277,624,440.88 for the quarter, contrasting with a decrease of -¥751,942,270.62 in the same quarter last year, indicating a positive cash flow trend[26] Assets and Liabilities - The total assets at the end of the reporting period were ¥19,695,631,410.72, a 0.74% increase from ¥19,551,531,971.61 at the end of the previous year[8] - The total assets of Tianbang Food Co., Ltd. as of March 31, 2023, amounted to CNY 19,695,631,410.72, an increase from CNY 19,551,531,971.61 at the beginning of the year[16] - Current assets reached CNY 4,780,424,819.05, up from CNY 4,321,760,122.54 at the start of the year, indicating a growth of approximately 10.6%[16] - The company's total equity attributable to shareholders decreased by 16.96%, from ¥3,914,950,536.79 to ¥3,251,067,875.39[8] - The total equity attributable to shareholders decreased to CNY 3,251,067,875.39 from CNY 3,914,950,536.79 at the beginning of the year[20] - The company reported a decrease in total liabilities to CNY 16,375,998,584.44 from CNY 15,565,938,493.67 at the beginning of the year[20] Operational Performance - Total operating revenue for Q1 2023 reached CNY 2,173,950,218.46, a 32.5% increase from CNY 1,639,594,622.68 in the same period last year[19] - Total operating costs amounted to CNY 2,733,199,092.59, up 19.9% from CNY 2,278,962,513.71 year-on-year[20] - The company experienced a significant increase in other income to CNY 19,039,590.69 from CNY 14,955,724.01 year-on-year[20] - Research and development expenses increased to CNY 8,599,877.77, up from CNY 6,762,751.13 in the previous year, reflecting a focus on innovation[20] Investment and Financial Activities - The company reported a 111.26% increase in investment income, attributed to dividends received from joint ventures[12] - The company’s financial expenses increased by 32.42%, primarily due to higher financing interest expenses[12] - The company’s cash flow from investing activities increased by 203.58%, driven by the receipt of the final payment for the disposal of a 51% stake in Shiji Biological[12] - The company experienced a 2900.33% increase in asset impairment losses due to the provision for consumable biological asset impairment[12] - The company's long-term equity investments slightly decreased to CNY 1,340,127,099.86 from CNY 1,354,256,161.35, a decline of about 1%[16] - The company reported a significant increase in other receivables, which rose to CNY 85,950,994.85 from CNY 548,578,504.29, reflecting a decrease of approximately 84.7%[16] - Accounts receivable rose to CNY 183,296,096.17, compared to CNY 62,275,834.07 at the beginning of the year, marking an increase of approximately 194.1%[16] - Inventory increased significantly to CNY 3,144,180,128.64 from CNY 2,631,545,098.91, reflecting a rise of about 19.5%[16] - Accounts payable surged to CNY 3,386,393,713.82 from CNY 2,827,505,842.43, indicating an increase of approximately 19.7%[16] - Short-term borrowings increased to CNY 2,643,552,447.21 from CNY 2,542,442,298.34, showing a rise of about 4%[16]

Financial Performance - Tianbang Food reported a total revenue of RMB 5.2 billion for the year 2022, representing a year-on-year increase of 15%[24]. - The net profit attributable to shareholders was RMB 600 million, up 10% compared to the previous year[24]. - The company's operating revenue for 2022 was ¥9,570,942,144.13, a decrease of 8.91% compared to ¥10,506,630,781.93 in 2021[30]. - The net profit attributable to shareholders was ¥489,451,284.99, representing a significant increase of 110.97% from a loss of ¥4,461,798,357.13 in 2021[30]. - The cash flow from operating activities improved to ¥658,267,768.09, a 218.46% increase from a negative cash flow of ¥555,707,470.19 in 2021[30]. - The basic earnings per share rose to ¥0.27, compared to a loss of ¥2.43 per share in 2021, marking an increase of 111.11%[30]. - The total operating revenue for 2022 was approximately ¥9.57 billion, a decrease of 8.91% compared to ¥10.51 billion in 2021[68]. - The revenue from pig farming increased by 9.18% to approximately ¥6.93 billion, accounting for 72.43% of total revenue[68]. - The revenue from food processing decreased by 17.10% to approximately ¥2.20 billion, representing 23.01% of total revenue[68]. - The revenue from feed products dropped significantly by 70.08% to approximately ¥428.69 million, making up 4.48% of total revenue[68]. Market Expansion and Strategy - The company plans to expand its market presence by increasing production capacity by 20% in 2023[24]. - The company has outlined a strategic goal to enter three new regional markets by the end of 2023[24]. - Future guidance estimates a revenue growth of 12% to 15% for 2023, driven by new product launches and market expansion[24]. - The company plans to enhance its pig meat processing capabilities and improve profitability through product development, supply chain optimization, and brand building[47]. - The company aims to achieve a pig output of 6.5 million heads in 2023, focusing on a combination of piglet and fattened pig sales strategies[110]. - The company plans to expand its integrated pig farming and slaughtering bases in high-consumption areas such as Beijing-Tianjin-Hebei, Yangtze River Delta, and Pearl River Delta[64]. - The company is exploring potential acquisitions in the aquaculture sector to enhance its supply chain efficiency[155]. - The company plans to strengthen its product innovation capabilities to enhance market share through brand loyalty and diversification[104]. Research and Development - Tianbang Food is investing RMB 200 million in R&D for new product development, focusing on health-oriented food products[24]. - In 2022, the company completed 20 R&D projects and filed 15 patents, including 4 invention patents and 11 utility model patents[61]. - The company is focusing on developing key technologies in animal nutrition and health, aiming to improve resource utilization and reduce costs[80]. - The company has implemented a full traceability system using electronic ear tags for pigs, enhancing food safety and monitoring of biological assets[62]. - The company completed the development of low-antigen hydrolyzed soybean meal, which significantly reduces anti-nutritional factors and improves animal digestion[81]. - The company is focusing on the development of fermentation feed rich in mannan oligosaccharides and probiotics, which helps improve gut health in animals[81]. Operational Efficiency - Tianbang Food is implementing new technologies in production to improve operational efficiency by 10%[24]. - The company is focusing on light asset models and expanding its rental farming model to improve biosecurity and production efficiency[65]. - The company has successfully implemented a partner system in 2022, which will be fully rolled out in 2023 to enhance management and production efficiency[113]. - The company aims to reduce operational costs by 5% through improved logistics and supply chain management initiatives[155]. - The company has established a risk management framework for its hedging activities, including a maximum guarantee amount of CNY 250 million[93]. Corporate Governance - The company conducted six shareholder meetings during the reporting period, ensuring equal rights for all shareholders[129]. - The company operates independently from its controlling shareholder, maintaining a complete production, supply, and sales system[130]. - The company has a transparent information disclosure system, ensuring timely and accurate communication with investors[136]. - The company has a structured compensation management system in place, which includes performance bonuses based on assessments by the remuneration and assessment committee[159]. - The company’s governance structure includes independent directors who play a crucial role in oversight and strategic decision-making[161]. Environmental Responsibility - The company has established a high-standard biosecurity prevention system and is actively investing in technology research and development to mitigate disease risks[118]. - The company has implemented pollution prevention facilities that are operational and compliant with regulations[191]. - The company has developed an emergency response plan for sudden environmental incidents and conducts regular training and drills[192]. - The company has undertaken social responsibility initiatives, as detailed in its social responsibility report[198]. - The company paid a total of 286,794.69 yuan in environmental protection taxes during the reporting period[194]. Employee Management - The total compensation for directors, supervisors, and senior management in 2022 amounted to 24.37 million yuan, with 18.21 million yuan classified as other compensation[161]. - The company has a total of 10,565 employees, with 3,821 having an education level of junior high school or below[173]. - The company organized training covering nearly 9,000 employees, including over 200 new core position employees and 400 university recruits, to improve job adaptability and professional skills[177]. - The company has implemented a performance management system that includes strategic maps and balanced scorecards to enhance organizational efficiency[174]. Challenges and Risks - The company faces significant risks from major diseases in the livestock industry, particularly African swine fever, which has caused substantial losses in recent years[118]. - Fluctuations in pork prices have led to cyclical changes in gross margins for the livestock industry, significantly impacting the company's operating performance[120]. - The cost of major raw materials, including wheat, corn, and soybean meal, accounts for over 50% of the company's operating costs, making it vulnerable to price volatility[122]. - Natural disasters such as droughts and floods pose risks to livestock operations, potentially damaging facilities and affecting transportation and sales[123].

证券代码：002124 证券简称：天邦食品 公告编号：2023-032 天邦食品股份有限公司 关于举办2022年度暨2023年第一季度现场业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 为加强上市公司投资者关系管理，同时便于广大投资者更全面深入地了解公司 2022年度和2023年第一季度的经营成果，天邦食品股份有限公司（以下简称"公司"） 定于2023年5月19日（星期五）下午16:00—18:00举行2022年度暨2023年第一季度现 场业绩说明会，就投资者关心的问题进行交流。 一、业绩说明会类型 本次业绩说明会通过现场会议交流的方式召开，本公司将针对 2022 年年度及 2023年第一季度业绩和经营情况与投资者进行交流，并对投资者普遍关注的问题进 行回答。 二、业绩说明会召开的时间、地点 （一）会议召开时间：2023年 5月19日（星期五）下午16:00—18:00 （二）会议召开地点：安徽省阜阳市临泉县拾分味道（临泉）食品有限公司多 功能厅 三、公司参会人员 独立董事：陈良华 财务总监：杜超 四、投资者参加方式 为方便广大投资者参会，保 ...

证券代码：002124 证券简称：天邦股份 宁波天邦股份有限公司投资者关系活动记录表 编号：2015-03 | --- | --- | --- | |--------------|-------------------------|------------------------------------------------------------| | | | | | 投资者关系活 | □ | 特定对象调研 □分析师会议 | | 动类别 | □媒体采访 □业绩说明会 | | | | □ | 新闻发布会 □路演活动 | | | ■现场调研 | | | | □ 其他 | | | 参与单位名称 | | 海通证券:丁频、陈雪丽；诺德基金:杨霞辉；融通基金 : 郭湛； | | 及人员姓名 | | 观富资产:张昊；潼骁投资:李彪；龙全投资:张宇麟；东方证券 : | | | 浦伟强 | | | 时间 | 2015 年 7 月 17 | 日 | | 地点 | 公司上海行政中心会议室 | | | 上市公司接待 | | | | 人员姓名 | | 副总裁兼董秘王韦、证券发展部胡宗田 | | 投资者关系活 | | 调研行业和公司 ...

证券代码：002124 证券简称：天邦股份 宁波天邦股份有限公司投资者关系活动记录表 编号：2015-01 | --- | --- | --- | |-------------------------|-------------------------|----------------------------------------------------------| | | | | | 投资者关系活 | □ | 特定对象调研 □分析师会议 | | 动类别 | □媒体采访 □业绩说明会 | | | | □ | 新闻发布会 □路演活动 | | | ■现场调研 | | | | □ 其他 | | | 参与单位名称 及人员姓名 | 长城证券 王建虎 | | | | | | | 时间 | 2015 年 3 月 18 | 日 | | 地点 | 公司上海行政中心会议室 | | | | | | | 上市公司接待 人员姓名 | | 副总裁兼董秘王韦、证券发展部胡宗田 | | 投资者关系活 | | 调研行业和公司情况（以调研机构提问，公司高管回答的方式 | | 动主要内容介 | 展开） | | | 绍 | | 问题一：如何看待 ...

Group 1: Company Strategy and Operations - The company aims to leverage opportunities in the internet era by building a smart platform that incorporates IoT and big data [3] - Short-term strategies focus on improving production and management efficiency, as well as enhancing sales channels [3] - The pig farming model is based on successful domestic experiences and collaboration with Pipestone in the U.S., promoting family farm models [3] Group 2: Business Segments and Future Outlook - The company originated from feed production and has expanded into pig farming and animal vaccines, which are key areas for future growth [3] - After the acquisition by Aigefi, improvements in feed quality, pig farming structure, traditional farm renovations, disease control, and personnel management have significantly reduced production and management costs, enhancing operational efficiency [3] - Some pig farms have achieved unit costs that are ahead of the industry average [3] Group 3: Research and Development - Continuous investment in R&D has led to improved capabilities, with notable performance growth in recent years [4] - The introduction of new products and the consolidation of advantages from the second-generation vaccine are expected to sustain performance growth this year [4]

编号：2016-07 证券代码：002124 证券简称：天邦股份 宁波天邦股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | |-----------------------|-----------------------------|-------------------------------------------------------------|--------------| | | | | | | 投资者关系活 | □ | 特定对象调研 □分析师会议 | | | 动类别 | □ | 媒体采访 □业绩说明会 | | | | □ | 新闻发布会 □路演活动 | | | | ■ 现场调研 □其他 | | | | 参与单位名称 | | 安信证券：李佳丰、郑颖欣；东北证券：于青青； | | | 及人员姓名 | | 光大证券：李雪飞；六禾投资：游晓慧；华富基金管理：许一 | | | 时间 | 2016 年 7 月 5 日 | | | | 地点 | 公司上海行政中心会议室 | | | | 上市公司接待 人员姓名 | | 战略管理与投资部总经理：胡宗田；证券发展部 : | 夏艳 ...

证券代码：002124 证券简称：天邦股份 宁波天邦股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | |-----------------------|-----------------------------|--------------------------------------------------------|------------------------|---------| | | | | 编号： | 2016-05 | | | | | | | | 投资者关系活 | □ | 特定对象调研 □分析师会议 | | | | 动类别 | □ | 媒体采访 □业绩说明会 | | | | | □ | 新闻发布会 □路演活动 | | | | 参与单位名称 | ■ 现场调研 □其他 | | | | | 及人员姓名 | 泰达宏利基金：周少博 | | | | | 时间 | 2016 年 6 月 7 日 | | | | | | | | | | | 地点 | 公司上海行政中心会议室 | | | | | 上市公司接待 人员姓名 | | 战略管理与投资部胡宗田、证券事务 ...

证券代码：002124 证券简称：天邦股份 | --- | --- | --- | --- | --- | |---------------------|-----------------------------|--------------------------------------------------------|--------|---------| | | | | 编号： | 2016-06 | | | | | | | | 投资者关系活 | □ | 特定对象调研 □分析师会议 | | | | 动类别 | □媒体采访 □业绩说明会 | | | | | | □ | 新闻发布会 □路演活动 | | | | | ■现场调研 □其他 | | | | | 参与单位名称 | | 财通证券 吕哲；银河证券 史凡可；国泰基金管理 饶玉涵； | | | | 及人员姓名 | 光大保德信基金管理 陆海燕。 | | | | | 时间 | 2016 年 6 月 28 | 日 | | | | 地点 上市公司接待 | 公司上海行政中心会议室 | | | | | 人员姓名 | | 董事会秘书张宇、证券事务代表夏艳 | | | ...